Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
Northwestern University · Lurie Children's Hospital · +18 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
253
total citations
- FWCI
- 49.70
- Percentile
- 100%
- References
- 36
Citations per year
Authors
58- ASAmy S. Paller
Northwestern University, Lurie Children's Hospital, Lurie Children's Hospital, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- ELEric L. Simpson
Oregon Health & Science University
- ECElaine C. Siegfried
St. Louis Children's Hospital, Cardinal Glennon Children’s Medical Center, Saint Louis University
- MJMichael J. Cork
University of Sheffield
- AWAndreas Wollenberg
Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Ludwig-Maximilians-Universität München
Topics & keywords
Topics
Keywords
- Medicine
- Atopic dermatitis
- Eczema Area and Severity Index
- Placebo
- Clinical endpoint
- Dupilumab
- SCORAD
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.